HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE ADVANCED SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kondo, S. Articles by Imaizumi, K. Search for Related Content PubMed PubMed Citation Articles by Kondo, S. Articles by Imaizumi, K.

¹ Division of Structural Cellular Biology, Nara Institute of Science and Technology (NAIST), 8916-5 Takayama, Ikoma, Nara 630-0101, Japan
² Department of Biochemistry and Molecular Biology, University of Miami School of Medicine, Miami, Florida 33136, USA

Some of mutations in the tau gene, which were found in frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), affect alternative splicing of its exon 10 which encodes one of four microtubule-binding motifs. To examine the molecular mechanisms responsible for aberrant splicing of the tau gene containing mutations linked to FTDP-17, we performed Exon trapping and binding assay using tau exon 10 pre-mRNA and nuclear extracts of neuroblastoma cell lines and in vitro splicing using dsx-substrate. We determined that 5' site of tau exon 10 (nucleotides 12–45) possesses exonic splicing enhancer (ESE) activities in vitro splicing and the FTDP-17-linked mutations affect the ESE activities and alter the splicing patterns of tau exon 10. Tra2ß directly and ASF/SF2 indirectly associated with the ESE of wild tau exon 10. The binding amounts of these SR proteins to tau exon 10 bearing N279K mutation increased and they enhanced splicing the mutant tau exon 10. SRp30c also enhanced the splicing of tau exon 10. These results suggest that mutations in tau exon 10 that are linked to FTDP-17 affect the ESE activities by altering the binding of some SR proteins to its pre-mRNA.

^* Correspondence: E-mail: imaizumi{at}bs.aist-nara.ac.jp

This article has been cited by other articles:

				J. Shi, T. Zhang, C. Zhou, M. O. Chohan, X. Gu, J. Wegiel, J. Zhou, Y.-W. Hwang, K. Iqbal, I. Grundke-Iqbal, et al. Increased Dosage of Dyrk1A Alters Alternative Splicing Factor (ASF)-regulated Alternative Splicing of Tau in Down Syndrome J. Biol. Chem., October 17, 2008; 283(42): 28660 - 28669. [Abstract] [Full Text] [PDF]

				M. O. Collins, L. Yu, I. Campuzano, S. G. N. Grant, and J. S. Choudhary Phosphoproteomic Analysis of the Mouse Brain Cytosol Reveals a Predominance of Protein Phosphorylation in Regions of Intrinsic Sequence Disorder Mol. Cell. Proteomics, July 1, 2008; 7(7): 1331 - 1348. [Abstract] [Full Text] [PDF]

				X. Zhang, A. N. Moor, K. A. Merkler, Q. Liu, and M. P. McLean Regulation of Alternative Splicing of Liver Scavenger Receptor Class B Gene by Estrogen and the Involved Regulatory Splicing Factors Endocrinology, November 1, 2007; 148(11): 5295 - 5304. [Abstract] [Full Text] [PDF]

				I. Taniguchi, K. Masuyama, and M. Ohno Role of purine-rich exonic splicing enhancers in nuclear retention of pre-mRNAs PNAS, August 21, 2007; 104(34): 13684 - 13689. [Abstract] [Full Text] [PDF]

				C. Paradis, P. Cloutier, L. Shkreta, J. Toutant, K. Klarskov, and B. Chabot hnRNP I/PTB can antagonize the splicing repressor activity of SRp30c RNA, August 1, 2007; 13(8): 1287 - 1300. [Abstract] [Full Text] [PDF]

				A. H. Mangs, H. J.L. Speirs, C. Goy, D. J. Adams, M. A. Markus, and B. J. Morris XE7: A novel splicing factor that interacts with ASF/SF2 and ZNF265 Nucleic Acids Res., October 18, 2006; 34(17): 4976 - 4986. [Abstract] [Full Text] [PDF]

				J. Y. Wu, A. Kar, D. Kuo, B. Yu, and N. Havlioglu SRp54 (SFRS11), a Regulator for tau Exon 10 Alternative Splicing Identified by an Expression Cloning Strategy. Mol. Cell. Biol., September 1, 2006; 26(18): 6739 - 6747. [Abstract] [Full Text] [PDF]

				I. D'Souza and G. D. Schellenberg Arginine/Serine-rich Protein Interaction Domain-dependent Modulation of a Tau Exon 10 Splicing Enhancer: ALTERED INTERACTIONS AND MECHANISMS FOR FUNCTIONALLY ANTAGONISTIC FTDP-17 MUTATIONS {Delta}280K AND N279K J. Biol. Chem., February 3, 2006; 281(5): 2460 - 2469. [Abstract] [Full Text] [PDF]

				Y. Wang, J. Wang, L. Gao, R. Lafyatis, S. Stamm, and A. Andreadis Tau Exons 2 and 10, Which Are Misregulated in Neurodegenerative Diseases, Are Partly Regulated by Silencers Which Bind a SRp30c{middle dot}SRp55 Complex That Either Recruits or Antagonizes htra2{beta}1 J. Biol. Chem., April 8, 2005; 280(14): 14230 - 14239. [Abstract] [Full Text] [PDF]